Mangalam Drugs And Organics Limited — Others, 15-11-2024: Copy of Newspaper Publication

Mangalam Drugs and Organics Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended September 30, 2024. The company reported total income from operations of ₹734.29 crore for the quarter, experiencing a net profit of ₹38.79 crore. Compared to the previous year's quarter, this reflects an increase in operational performance. The update suggests improved financial health, which could positively influence investor sentiment, presenting opportunities for growth amidst evolving market conditions.